An enterotoxigenic strain of Escherichia coli, B34289c, has been shown to bind the N-terminal region of fibronectin with high affinity (G. Froman, L. M. Switalski, A. Faris, T. Wadstrom, and M. Hook, J. Biol. Chem. 259:14899-14905, 1984). We now report that this strain also binds collagen. 
bacterial cell surface. Bacteria grown at 41°C or in the presence of glucose did not express collagen or fibronectin receptors. These results indicate the presence of specific binding sites for collagen on the surface of E. coli cells and furthermore that the collagen and fibronectin binding sites are located in close proximity, possibly on the same structure.
The collagens constitute a heterogeneous family of fibrous proteins that represent major components of the extracellular matrix. In the connective tissues they mostly play a structural role; for instance, they give support to the bone and tensile strength to ligaments and tendons, and the arrangement of collagen fibrils confers transparency to the cornea.
Collagens may also affect biological activities of the cell, such as cell attachment (4, 6, 34) , migration (33) , and proliferation (1) , as well as cell differentiation during hematopoiesis (26) and organogenesis (14) . Eucaryotic cells express different cell surface receptors for collagen (5, 21) . Membrane proteins that bind various types of collagen have been identified for a number of cell types (7, 22, 23, 29) . Hence, collagen can be regarded as an adhesive protein and in this regard shares many properties with other adhesive proteins such as fibronectin and laminin.
Recent studies have shown that several pathogenic bacteria bind to extracellular matrix proteins such as fibronectin (10, 11, 24, (35) (36) (37) , laminin (27, 38, 43, 48) , and collagen (15, 16, 39, 40) . For instance, streptococci (39) and strains of Staphylococcus aureus, particularly those isolated from septic arthritis, osteomyelitis, and infective endocarditis (16) , express collagen receptors. Bacterial receptors for collagen and other connective tissue proteins have been proposed as potential virulence factors that may determine the ability of bacteria to adhere and colonize a tissue. Enterotoxigenic strains of Escherichia coli may cause severe diarrhea in humans and young animals (12). The pathogenesis of this infection involves the ability of bacteria to adhere to the small intestine epithelium and the production of noncytotoxic enterotoxins.
Enterotoxigenic E. coli strains produce heat-labile or heat-stable toxins (12, 13) or both (32) . However, entero-* Corresponding author. toxin production alone does not appear sufficient to make an enterotoxigenic strain pathogenic. Several fimbrial adhesins differing in their serological properties and binding specificity have been identified in enterotoxigenic strains of E. coli isolated from humans (colonization factdt antigens CFA/ I, CFA/II, and CFA/III) (17) .
Furthermore, some enterotoxigenic E. coli strains bind fibronectin, and it has been postulated that binding to fibronectin may represent a mechanism of tissue adherence (10) . Along this line we have characterized the binding of collagen to the enterotoxigenic strain E. coli B34289c and compared it with the binding of fibronectin to the same strain.
In this report, we present data to show that collagen binding to E. coli is a receptor-mediated reaction and that collagen and fibronectin recognize the same structure or two closely spaced components on the surface of this microorganism. We propose that the binding of collagen and fibronectin to E. coli may represent a mechanism whereby these bacteria adhere to small intestine.
MATERIALS AND METHODS Chemicals. Type II collagen was purified from bovine nasal septum as described by Strawich and Nimmi (41) . Isolation of native collagen types I through V was as described previously (40) . The cyanogen bromide peptides (CB peptides) were generated by treatment of alpha chains with cyanogen bromide and purified as described previously (2) .
Carrier-free 1251 (specific activity, 15 mCi/,ug) was purchased from Radiochemical Centre, Amersham, England. Proteins were labeled with 1251 by the chloramine T method (18) . The Fibronectin was purified from human plasma as described previously (45) . Thermolysin-generated fragments (3) 125I-labeled type II collagen in 0.6 ml of phosphate-buffered saline containing 0.1% bovine serum albumin and 0.1% Tween 80 to block unspecific binding to cells and tubes and rotated in an end-over-end mixer at 22°C for the indicated times. Incubation was stopped by the addition of 2.5 ml of ice-cold 0.1% Tween 80 in phosphate-buffered saline, and the tubes were centrifuged at 1,400 x g for 15 min. After removal of the supernatant, the radioactivity associated with the cell pellet was determined in a y counter (LKB Wallac, Turku, Finland).
The radioactivity recovered in the pellet after centrifugation of a reaction mixture incubated in the absence of bacteria was considered as background and was subtracted from that of the samples containing bacteria. Under these conditions the background radioactivity (1,000 to 1,500 cpm) was identical to that obtained in controls, in which 125I1 labeled collagen was incubated with bacteria in the presence of 100 ,ug of unlabeled collagen. Samples and controls were run in triplicate. (Fig. 2) . The reaction was rapid and essentially completed within 60 min. Prolonged incubations resulted in little additional binding of 1251I-labeled collagen. When heatkilled bacteria were incubated with collagen, binding kinetics were slower and the amount of ligand bound was 60% lower than those in live cells. Therefore, live bacteria were used throughout this study, and the cells were routinely incubated with the ligand for 60 min.
The collagen-binding potential of the bacterial cells varied with the temperature at which bacteria were cultured (Fig.  3 ( Fig. 3) . To analyze the effects of the growth temperature further, E. coli cells were first grown at 41°C for 24 h. After this incubation the bacteria were spread on agar plates and subcultured at 30°C for an additional 24 h. The cells harvested under these conditions and assayed for their ability to bind radioactively labeled ligands showed complete recovery of their binding capacity for collagen and for the Nterminal fragment of fibronectin. The expression of both fibronectin and collagen receptors was repressed in bacteria grown in medium supplemented with 1% glucose. However, collagen and fibronectin binding was not suppressed by the addition of cyclic AMP to the culture medium, which might rule out the possibility of a cyclic AMP-mediated catabolite repression of receptor expression (44) . The reversibility of the collagen binding to bacteria was examined. Cells were first incubated for 1 h with 20 ng of 125I-labeled collagen, and then a 10,000-fold excess (200 R,g) of unlabeled collagen was added to the incubation mixture. The addition of unlabeled collagen resulted in the displacement of two-thirds of the labeled ligand over a 3-h incubation (Fig. 4) .
When the bacteria were incubated with increasing concentrations of 125I-labeled collagen, the amount of ligand bound to the bacteria increased to a saturation level of 5.50 ,ug of collagen bound per 5 x 108 cells at a collagen concentration of 25 p.g/0.6 ml (Fig. 5) . If we assume a molecular weight of 2.85 x 105 for collagen (28) and that all the 1251I-collagen associated with bacteria represents receptor-bound ligand, the average number of available collagen-binding sites per cell is 2.2 x 104. Scatchard plot analysis of the binding data revealed a straight line (Fig. 5, inset) collagen binding to bacteria. The results of these experiments (Table 2) showed that the inhibitory activity of fibronectin was located in the N-terminal domain, which was previously shown to bind to E. coli cells (10 (Fig. 6) . All the collagen types tested, including types I to V, were potent inhibitors and showed essentially the same inhibitory potential when tested at different concentrations. On the contrary, the binding of 1251-labeled collagen to bacteria in the presence of catalase was not significantly reduced. When different collagen peptides isolated after degradation of type I collagen with cyanogen bromide were included in the incubation mixture (Fig. 7) , they all inhibited the binding of 125I-labeled collagen to bacteria, although the extent of inhibition varied. In general, small fragments [al(I)CB2 and Fig. 8 and data not shown) .
In separate experiments we tried to displace 125I-labeled collagen bound to bacteria by adding unlabeled intact fibronectin or its 28-kDa fragment. Both fibronectin and its N-terminal domain were as efficient as unlabeled collagen in displacing 125I-labeled collagen from the bacterial cell surface (Fig. 9A) . The reverse was also true; i.e., the 125I-labeled N-terminal fragment bound to bacteria could be released by unlabeled collagen (Fig. 9B) . DISCUSSION Data reported from several laboratories, including ours, have shown that both staphylococci and streptococci bind collagen. Collagen binds to a number of streptococcal strains belonging to serogroups A, B, C, D, and G (39) and to different species of staphylococci (47) . Some gram-negative oral bacteria such as Bacterioides gingivalis bind type IV collagen (49 mately 20 nM and of the same order of magnitude as that of collagen for S. aureus Cowan 1 (40) . However, in view of several assumptions made, e.g., the approximation in determining the specific activity of 1251I-labeled collagen, these values should be regarded as rough estimates.
Bacterial receptors recognized all of the collagen types tested. Also, CB peptides generated by cyanogen bromide cleavage of type I collagen were efficient inhibitors. Large cyanogen bromide fragments had an apparent affinity higher than that of smaller ones. The fact that all collagen types and CB peptides inhibited the binding of 1251I-labeled collagen to E. coli cells indicates that the E. coli collagen receptor recognizes a structure common to all collagen and that collagen contains multiple binding sites for bacteria along the molecule. A similar specificity was previously shown for a collagen receptor on S. aureus (40) .
Binding of 125I-labeled collagen was specific; it was completely inhibited by an excess of either unlabeled collagen or VOL. 58, 1990 on January 11, 2018 by guest http://iai.asm.org/ Downloaded from gelatin. Most other unrelated proteins did not affect the binding. The lack of inhibition by an immunoglobulin G antibody to the collagen receptor of S. aureus, which blocks collagen binding to these bacteria (data not shown), indicates that the collagen receptors from the two species are different. Fetuin reduced the binding of collagen to bacteria to some extent. The mechanism of this effect remains unclear.
Binding of collagen to bacteria was reversible, and most cell-bound '25I-labeled collagen could be displaced by unlabeled ligand. Collagen was apparently not degraded during incubation with E. coli, as indicated by electrophoresis on polyacrylamide gel of '25I-labeled collagen before and after 1 h of incubation (data not shown). Furthermore, chloramine T labeling of collagen did not modify electrophoretic behavior of the protein (Fig. 1) . Taken together, these results rule out the possibility that incomplete displacement of radiolabeled collagen bound to the E. coli cell surface by unlabeled collagen may reflect the presence of two or more types or sizes of collagen in the incubation mixture. The partial reversibility may indicate that, after initial binding of collagen to bacteria via a receptor, other interactions could occur that make the final binding tight and irreversible.
The expression of both collagen and fibronectin receptors in E. coli was dependent on the growth temperature in a parallel fashion and was prevented by the presence of 1% glucose in the growth medium. The effect of glucose is unclear, although a mechanism of cyclic AMP control appears to be excluded.
Several lines of evidence demonstrate that the collagenand fibronectin-binding sites on E. coli are located in close proximity and possibly on the same structure or molecule. First, of the fibronectin fragments tested, only the N-terminal fragment strongly inhibited the binding of collagen to bacteria, whereas other fragments, including a collagenbinding fragment, were essentially inactive. Second, CB peptides that lacked affinity for fibronectin [i.e., oal(I)CB8] were more effective in inhibiting the binding of collagen to the bacterial cells than peptides containing the fibronectin binding site [i.e., al(I)CB7]. Third, the binding of the 125I-labeled N-terminal fragment of fibronectin to bacteria was equally inhibited by both unlabeled collagen and by the N-terminal region of fibronectin. Finally, this conclusion is supported by displacement experiments, in which unlabeled fibronectin or its N-terminal fragment effectively displaced bound 1251-labeled collagen from E. coli cells or, conversely, unlabeled collagen was successfully used to reverse the binding of radiolabeled 28-kDa fragment to bacteria. Taken together, these observations highlight the possibility that the same cell surface structure may act as a receptor for collagen and fibronectin and perhaps other adhesive proteins. The bacterial receptor site may recognize the same active sequence in both collagen and fibronectin; alternatively, collagen and fibronectin may each have distinct domains that interact with different subsites that are close together on the receptor molecule.
In a recent study, Olsdn et al. (30) identified in E. coli isolates a novel class of surface organelles, named curli, that mediate binding of bacteria to fibronectin. Curli were found to consist of a single type of protein, the curlin, and their assembly occurred preferentially at growth temperatures below 37°C. It is not currently known whether curli are also involved in collagen binding.
E. coli B34289c, besides specifically interacting with collagen and fibronectin, also binds to laminin, the most abundant glycoprotein in basement membranes (data not shown). The biological significance of the specific binding of colla- Additional studies will be required to assess whether these interactions represent a critical event in bowel infection processes.
